The latest news
VOC Diagnostics raises 4.8M SEK
VOC Diagnostics are very happy to announce that Almi Invest, together with several private investors, are investing in the company. The money will contribute to continued clinical studies, further product development and preparation for CE-marking.
Linda Spahiu recruited as new CEO
We are happy to welcome Linda Spahiu as CEO. Linda has broad experience from the Life Science industry. She holds a M.Sc. in engineering and biotechnology from KTH and a Ph.D. in enzymology from Karolinska Institutet.
The Board is strengthened with additional medical skills. We welcome Dr. Nils Crona from Sahlgrenska University Hospital.
Vi välkomnar doc. Nils Crona från Sahlgrenska Universitetssjukhus.
Ser-ies test of 2 instruments will begin during week 45 - 46.
We are happy to strengthen VOC Diagnostics by a CEO, Annika Ericson from 2019-03-01. Annika has a long history within the pharma industry and especially in roles within field of oncology. She has a MSc in Biology from Stockholm University and an MBA from Heriott-Watt University, Edinburgh.